207 related articles for article (PubMed ID: 6244836)
41. Membraneous and cytosolic cyclic-nucleotide phosphodiesterases in beef aorta: substrate specificity, endogenous inhibition and activation [proceedings].
Ilien B; Morel A; Stierle A; Landry Y
Arch Int Physiol Biochim; 1978 Oct; 86(4):865-7. PubMed ID: 84582
[No Abstract] [Full Text] [Related]
42. Cyclic nucleotide phosphodiesterases.
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():1-416. PubMed ID: 6326516
[No Abstract] [Full Text] [Related]
43. Characterization of cyclic nucleotide phosphodiesterases from cultured bovine aortic endothelial cells.
Lugnier C; Schini VB
Biochem Pharmacol; 1990 Jan; 39(1):75-84. PubMed ID: 2153383
[TBL] [Abstract][Full Text] [Related]
44. Effects of cyclic nucleotide phosphodiesterases (PDEs) on mitochondrial skeletal muscle functions.
Tetsi L; Charles AL; Paradis S; Lejay A; Talha S; Geny B; Lugnier C
Cell Mol Life Sci; 2017 May; 74(10):1883-1893. PubMed ID: 28039524
[TBL] [Abstract][Full Text] [Related]
45. Stimulation of hamster adipocyte cyclic 3':5'-nucleotide phosphodiesterase activity by ionophore A23187 and calcium.
Nemecek GM
J Cyclic Nucleotide Res; 1978 Aug; 4(4):299-309. PubMed ID: 214467
[TBL] [Abstract][Full Text] [Related]
46. [Properties of 3':5'-AMP- and 3':5'-GMP-phosphodiesterases in the retina].
Usova AA
Ukr Biokhim Zh (1978); 1979; 51(1):35-40. PubMed ID: 218330
[TBL] [Abstract][Full Text] [Related]
47. Cyclic nucleotide metabolism in the mouse spleen after treatment with tilorone hydrochloride.
Römer W; Zschiesche W
Acta Biol Med Ger; 1979; 38(5-6):791-4. PubMed ID: 43058
[No Abstract] [Full Text] [Related]
48. Cyclic nucleotides phosphodiesterase activity changes in early chick development.
Neuman T
Experientia; 1983 Jan; 39(1):96-7. PubMed ID: 6297959
[TBL] [Abstract][Full Text] [Related]
49. Regulation of cyclic AMP and cyclic GMP in Morris hepatomas and liver.
Hickie RA
Adv Exp Med Biol; 1977 May 22-24; 92():451-88. PubMed ID: 24988
[No Abstract] [Full Text] [Related]
50. Selective inhibitors of three forms of cyclic nucleotide phosphodiesterase--basic and potential clinical applications.
Hidaka H; Endo T
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():245-59. PubMed ID: 6144253
[No Abstract] [Full Text] [Related]
51. Age-induced differentiation of morphine's effect on cyclic nucleotide metabolism.
Hoskins B; Ho IK
Neurobiol Aging; 1987; 8(5):473-6. PubMed ID: 2891056
[TBL] [Abstract][Full Text] [Related]
52. Comparison of cyclic adenosine 3':5'-monophosphate and cyclic guanosine 3':5'-monophosphate levels, cyclases, and phosphodiesterases in Morris hepatomas and liver.
Hickie RA; Thompson WJ; Strada SJ; Couture-Murillo B; Morris HP; Robison GA
Cancer Res; 1977 Oct; 37(10):3599-606. PubMed ID: 20224
[No Abstract] [Full Text] [Related]
53. Chromatographic behavior of cyclic 3',5'-nucleotide phosphodiesterases on columns of immobilized inhibitors.
Mohindru A; Chenet A; Rhoads AR
Biochemistry; 1978 Aug; 17(16):3297-304. PubMed ID: 80229
[No Abstract] [Full Text] [Related]
54. Characterization of a cAMP/cGMP phosphodiesterase sensitive to calmodulin [proceedings].
Ilien B; Landry Y
Arch Int Physiol Biochim; 1980 Feb; 88(1):B32-B33. PubMed ID: 6155846
[No Abstract] [Full Text] [Related]
55. Cyclic nucleotide phosphodiesterase localization in nerve terminals of the rat substantia nigra.
Minneman KP; Cuello AC
J Neurochem; 1979 Aug; 33(2):587-91. PubMed ID: 224146
[No Abstract] [Full Text] [Related]
56. Cyclic AMP phosphodiesterase and cyclic GMP phosphodiesterase activities of rat mammary tissue.
Mullaney I; Clegg RA
Biochem J; 1984 May; 219(3):801-9. PubMed ID: 6331397
[TBL] [Abstract][Full Text] [Related]
57. Characteristics of the cyclic nucleotide phosphodiesterases in a transplantable pheochromocytoma and adrenal medulla of the rat.
Levin RM; Weiss B
Cancer Res; 1978 Apr; 38(4):915-20. PubMed ID: 205349
[No Abstract] [Full Text] [Related]
58. The metabolism of cyclic nucleotides in the guinea-pig pancreas. Cyclic AMP phosphodiesterase and cyclic GMP phosphodiesterase.
Methven P; Lemon M; Bhoola K
Biochem J; 1980 Feb; 186(2):491-8. PubMed ID: 6246887
[TBL] [Abstract][Full Text] [Related]
59. Cyclic nucleotide phosphodiesterase of normal and leukemic lymphocytes. Kinetic properties and selective alteration of the activity of the multiple molecular forms.
Hait WN; Weiss B
Mol Pharmacol; 1979 Nov; 16(3):851-64. PubMed ID: 231197
[No Abstract] [Full Text] [Related]
60. Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form.
Lavan BE; Lakey T; Houslay MD
Biochem Pharmacol; 1989 Nov; 38(22):4123-36. PubMed ID: 2480793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]